In Week of Mar 28, 2026, Star Health & Allied Insurance Company Ltd (Finance - Non Life Insurance) is outperforming Nifty 500 with +14.8% relative strength. Fundamentals: Weak. On a 4-week streak.
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
Based on Q3 FY26 earnings • Updated Mar 7, 2026
What: Q3 loss ratio improved to 68.8% from 71.88% YoY, driving combined ratio below 100%
Impact: +₹46 Cr revenue
“Q3 FY26 earnings call transcript: 'We reported India's underwriting profit of 46 crores in quarter 3 FY26 as compared to an underwriting loss of 79 crores in quarter 3 FY25'”
What: Fresh business growth of 45% driving overall GWP growth of 23% in Q3
Impact: +₹1830 Cr revenue
“Q3 FY26 earnings call transcript: 'Our gross premium increased 23% year-on-year by fresh business growth of 45% and the renewal premium growth of 17%'”
What: Expense ratio improved to 29.8% for 9M period from 30.8% YoY
“Q3 FY26 earnings call transcript: 'Our expense ratio also improved by close to 100 basis points to 29.8% for the nine month period'”
Earnings deceleration risks from management commentary
Trigger: Loss ratio improvements may not be linear
Management view: These things to flow into the loss ratio and the earned premium takes, you know, 18 to 20, 24 months. So we are still not even 12 months done.
Monitor: Retail loss ratio trajectory
Key quotes from recent conference calls
“We reported India's underwriting profit of 46 crores in quarter 3 FY26 as compared to an underwriting loss of 79 crores in quarter 3 FY25. This was driven uh by improvement in the combined ratio by almost 320 basis points from 102.1 in quarter 3 FY25 to 98.9 in quarter 3 FY26. — Anand Roy”
“As in the previous quarters, we have demonstrated loss ratio decline continuously in successive quarters with a 301 basis points decrease from 71.8 8 in quarter 3 FY25 to 68.8 in quarter 3 FY26. The retail loss ratios also have decreased by 103 basis points year on year to 68.4% in this quarter. — Anand Roy”
“We are delivering more than 16% growth in volume in quarter three. So things are improving on the NOP as well. — Anand Roy”
“On pricing, we took up the last year in Q4 and we will be following the annual price cycle as it is. As far as the cohort based pricing approach that we took for fho, that has given us very good results. We are clearly seeing a good lift in terms of the non payments and the risk that healthy take, giving us better retentions. — Unidentified Speaker”
Forward-looking targets from management for 9M FY26
Revenue Growth Target
16%
Implied PAT Growth
87%
Key Milestones
• Maintain combined ratio below 100%
• Achieve mid-teens ROE
• Sustain new business growth above 40%
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +10% | +15% | Stable |
| PAT (Net Profit) | -40% | +37% | Stable |
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Mar 7, 2026.
Based on publicly available financial data. This is educational research, not investment advice.
Star Health & Allied Insurance Company Ltd's latest quarterly results (Dec 2025) show
Star Health & Allied Insurance Company Ltd's profit is declining with an stable trend.
Star Health & Allied Insurance Company Ltd's revenue growth trend is stable.
Star Health & Allied Insurance Company Ltd's asset quality trend is insufficient_data.
Star Health & Allied Insurance Company Ltd's long-term compounding rates
Star Health & Allied Insurance Company Ltd's earnings growth is stable with mixed signals on a sequential basis.
Star Health & Allied Insurance Company Ltd's trailing twelve month (TTM) performance
Star Health & Allied Insurance Company Ltd appears significantly overvalued based on our fair value analysis.
Star Health & Allied Insurance Company Ltd's current PE ratio is 60.3x.
Star Health & Allied Insurance Company Ltd's current PE is 60.3x.
Star Health & Allied Insurance Company Ltd's price-to-book ratio is 3.6x.
Star Health & Allied Insurance Company Ltd is rated Weak with a fundamental score of 35/100. This score is calculated from objective financial metrics
Star Health & Allied Insurance Company Ltd has a debt-to-equity ratio of N/A.
Star Health & Allied Insurance Company Ltd's return ratios over recent years
Star Health & Allied Insurance Company Ltd's operating cash flow is positive (FY2025).
Star Health & Allied Insurance Company Ltd currently does not pay a significant dividend (yield 0.00%).
Star Health & Allied Insurance Company Ltd's shareholding pattern (Dec 2025)
Star Health & Allied Insurance Company Ltd's promoter holding has decreased recently.
Star Health & Allied Insurance Company Ltd has been outperforming Nifty 500 for 4 consecutive weeks, indicating building momentum.
Star Health & Allied Insurance Company Ltd is an established outperformer with 4 weeks of consecutive Nifty 500 outperformance.
Star Health & Allied Insurance Company Ltd has 3 key growth catalysts identified from recent earnings analysis
Star Health & Allied Insurance Company Ltd has 1 key risk worth monitoring
In Q3 FY26, Star Health & Allied Insurance Company Ltd's management highlighted
Star Health & Allied Insurance Company Ltd's management has provided the following forward guidance for 9M FY26
Based on quantitative research signals, here is why Star Health & Allied Insurance Company Ltd may be worth studying
Star Health & Allied Insurance Company Ltd investment thesis summary:
Star Health & Allied Insurance Company Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.
